eRapa Recieves FDA Fast Track Designation for Familial Adenomatous Polyposis
The Fast Track Designation was granted to Biodexa Pharmaceuticals’ eRapa based on phase 2 data showing its safety and tolerability in adults with FAP.
Related Articles
Unraveling Myelofibrosis: A Complex Patient Case Series
Let our myelofibrosis experts guide you through choosing the best therapies for complex cases!
A Year After Super Bowl Parade Shooting, Trauma Freeze Gives Way to Turmoil for Survivors – KFF Health News
Survivors and witnesses of gun violence often freeze emotionally at first, as a coping mechanism. As the one-year mark since the parade shooting nears, the…
A man volunteered to get brain implants for depression. Hear his story
In the first episode of The Deep End Podcast, we meet Jon Nelson, who shares why he volunteered to get brain implants for his relentless…
Co-administration of seasonal quadrivalent influenza and COVID-19 vaccines leads to enhanced immune responses to influenza virus and reduced immune responses to SARS-CoV-2 in naive mice – PubMed
The ongoing co-circulation of influenza viruses and severe acute respiratory disease coronavirus 2 (SARS-CoV-2) presents significant public health challenges. Vaccination is a pivotal tool to…
22 states sue Trump admin over health research funding cuts | CNN
Dr. Jeffrey Flier and Dr. Theodore Iwashyna join The Lead
Evernorth study: A look at the progress toward value-based care in behavioral health
Behavioral health has lagged behind in the shift to value-based care, and
Gut Microbial TMAO Pathway Associated With Incident Heart Failure
What do dietary substrates, gut microbe metabolites and heart failure have in common? Our latest research reveals a fascinating link. Our researchers have identified a…
‘Real-life Iron Man’ strikes deal with military to use his JET SUIT
British engineer Richard Browning, known as the ‘real-life Iron Man’, is on a mission to bring jet packs to the military.
Anaphylaxis Following Non-COVID Vaccines Are Rare but Vary by Type
An analysis found anaphylaxis following non-COVID vaccines is rare, with greater rates for yellow fever and influenza vaccines.
GLP-1 Meds Can Work Wonders for Kidney Health
TUESDAY, Feb. 11, 2025 (HealthDay News) — Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for fo